Literature DB >> 18753145

Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.

Bert Blaauw1, Cristina Mammucari, Luana Toniolo, Lisa Agatea, Reimar Abraham, Marco Sandri, Carlo Reggiani, Stefano Schiaffino.   

Abstract

Skeletal muscles of the mdx mouse, a model of Duchenne Muscular Dystrophy, show an excessive reduction in the maximal tetanic force following eccentric contractions. This specific sign of the susceptibility of dystrophin-deficient muscles to mechanical stress can be used as a quantitative test to measure the efficacy of therapeutic interventions. Using inducible transgenesis in mice, we show that when Akt activity is increased the force drop induced by eccentric contractions in mdx mice becomes similar to that of wild-type mice. This effect is not correlated with muscle hypertrophy and is not blocked by rapamycin treatment. The force drop induced by eccentric contractions is similar in skinned muscle fibers from mdx and Akt-mdx mice when stretch is applied directly to skinned fibers. However, skinned fibers isolated from mdx muscles exposed to eccentric contractions in vivo develop less isometric force than wild-type fibers and this force depression is completely prevented by Akt activation. These experiments indicate that the myofibrillar-cytoskeletal system of dystrophin-deficient muscle is highly susceptible to a damage caused by eccentric contraction when elongation is applied in vivo, and this damage can be prevented by Akt activation. Microarray and PCR analyses indicate that Akt activation induces up-regulation of genes coding for proteins associated with Z-disks and costameres, and for proteins with anti-oxidant or chaperone function. The protein levels of utrophin and dysferlin are also increased by Akt activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18753145     DOI: 10.1093/hmg/ddn264

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  36 in total

1.  Lack of the serum- and glucocorticoid-inducible kinase SGK1 improves muscle force characteristics and attenuates fibrosis in dystrophic mdx mouse muscle.

Authors:  Martin Steinberger; Michael Föller; Silke Vogelgesang; Mirjam Krautwald; Martin Landsberger; Claudia K Winkler; Joachim Kasch; Ernst-Martin Füchtbauer; Dietmar Kuhl; Jakob Voelkl; Florian Lang; Heinrich Brinkmeier
Journal:  Pflugers Arch       Date:  2014-11-14       Impact factor: 3.657

2.  Biomechanics of the sarcolemma and costameres in single skeletal muscle fibers from normal and dystrophin-null mice.

Authors:  K P García-Pelagio; R J Bloch; A Ortega; H González-Serratos
Journal:  J Muscle Res Cell Motil       Date:  2011-02-11       Impact factor: 2.698

3.  Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.

Authors:  Natassia M Vieira; Janelle M Spinazzola; Matthew S Alexander; Yuri B Moreira; Genri Kawahara; Devin E Gibbs; Lillian C Mead; Sergio Verjovski-Almeida; Mayana Zatz; Louis M Kunkel
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

4.  Genetic deletion of trkB.T1 increases neuromuscular function.

Authors:  Susan G Dorsey; Richard M Lovering; Cynthia L Renn; Carmen C Leitch; Xinyue Liu; Luke J Tallon; Lisa DeShong Sadzewicz; Abhishek Pratap; Sandra Ott; Naomi Sengamalay; Kristie M Jones; Colleen Barrick; Gianluca Fulgenzi; Jodi Becker; Kevin Voelker; Robert Talmadge; Brandon K Harvey; Ryan M Wyatt; Elizabeth Vernon-Pitts; Chao Zhang; Kevan Shokat; Claire Fraser-Liggett; Rita J Balice-Gordon; Lino Tessarollo; Christopher W Ward
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-05       Impact factor: 4.249

5.  MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi; Natássia M Vieira; Iris Eisenberg; Jamie L Marshall; Molly J Gasperini; Angela Lek; Jennifer A Myers; Elicia A Estrella; Peter B Kang; Frederic Shapiro; Fedik Rahimov; Genri Kawahara; Jeffrey J Widrick; Louis M Kunkel
Journal:  J Clin Invest       Date:  2014-05-01       Impact factor: 14.808

6.  Microtubules underlie dysfunction in duchenne muscular dystrophy.

Authors:  Ramzi J Khairallah; Guoli Shi; Francesca Sbrana; Benjamin L Prosser; Carlos Borroto; Mark J Mazaitis; Eric P Hoffman; Anup Mahurkar; Fredrick Sachs; Yezhou Sun; Yi-Wen Chen; Roberto Raiteri; W Jonathan Lederer; Susan G Dorsey; Christopher W Ward
Journal:  Sci Signal       Date:  2012-08-07       Impact factor: 8.192

7.  The chondrogenic response to exercise in the proximal femur of normal and mdx mice.

Authors:  David J Nye; Jeffrey M Costas; Jessica B Henley; Jin-Kwang Kim; Jeffrey H Plochocki
Journal:  BMC Musculoskelet Disord       Date:  2010-09-03       Impact factor: 2.362

8.  The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice.

Authors:  Ashwani Mittal; Shephali Bhatnagar; Akhilesh Kumar; Estelle Lach-Trifilieff; Sandrine Wauters; Hong Li; Denys Y Makonchuk; David J Glass; Ashok Kumar
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

Review 9.  Therapeutic targeting of signaling pathways in muscular dystrophy.

Authors:  Shephali Bhatnagar; Ashok Kumar
Journal:  J Mol Med (Berl)       Date:  2009-10-09       Impact factor: 4.599

10.  Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.

Authors:  Valérie Risson; Laetitia Mazelin; Mila Roceri; Hervé Sanchez; Vincent Moncollin; Claudine Corneloup; Hélène Richard-Bulteau; Alban Vignaud; Dominique Baas; Aurélia Defour; Damien Freyssenet; Jean-François Tanti; Yannick Le-Marchand-Brustel; Bernard Ferrier; Agnès Conjard-Duplany; Klaas Romanino; Stéphanie Bauché; Daniel Hantaï; Matthias Mueller; Sara C Kozma; George Thomas; Markus A Rüegg; Arnaud Ferry; Mario Pende; Xavier Bigard; Nathalie Koulmann; Laurent Schaeffer; Yann-Gaël Gangloff
Journal:  J Cell Biol       Date:  2009-12-14       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.